Citeline Podcasts

Device Week, 19 November 2020 – Glooko Exec Chat; Boston Scientific Kills Lotus TAVR by Citeline

Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.

On this week’s podcast: The US FDA is plotting a pilot program that will allow agency investigators to conduct virtual facility inspections; enforcement experts say pandemic cleanup efforts could last for years; a peek ahead as to how quickly President-elect Joe Biden will fill top roles at the HHS and the FDA; and more.

Medtech Insight articles addressing topics discussed in this episode:

•FDA Quietly Plots Pilot Program For Virtual Inspections As Pandemic Rages On

https://medtech.pharmaintelligence.informa.com/MT143051/FDA-Quietly-Plots-Pilot-Program-For-Virtual-Inspections-As-Pandemic-Rages-On

•Enforcement Experts: COVID-19 Backlog Could Last Years

https://medtech.pharmaintelligence.informa.com/MT143059/Enforcement-Experts-COVID-19-Backlog-Could-Last-Years

•Experts: Biden Will Rush To Fill HHS, FDA Posts; Georgia Senate Races May Decide ACA’s Fate

https://medtech.pharmaintelligence.informa.com/MT143054/Experts-Biden-Will-Rush-To-Fill-HHS-FDA-Posts-Georgia-Senate-Races-May-Decide-ACAs-Fate

•Attorneys, Insurers Disagree With Manufacturers On Need For Clinical Evidence For MCIT Coverage

https://medtech.pharmaintelligence.informa.com/MT143058/Attorneys-Insurers-Disagree-With-Manufacturers-On-Need-For-Clinical-Evidence-For-MCIT-Coverage

Pink Sheet reporters and editor discuss the potential changes at the FDA under President-elect Biden and the take-aways from the negative advisory committee recommendation for Biogen’s proposed Alzheimer’s drug aducanumab.

Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.

In this week’s podcast, Medtech Insight's managing editor Marion Webb discusses how the US Preventive Services Task Force’s recommendations to lower colon screening to age 45 may impact Exact Sciences’ Cologuard stool test. Deputy editor Reed Miller highlights third-quarter results of Stryker, Boston Science and Edwards Lifesciences.

Listen to the podcast via the player below:

Stryker Sees ‘V-Shape’ Recovery In Third Quarter

Boston Scientific Exceeds Wall Street’s Expectations In Q3

Edwards Returns To Growth In The Third Quarter

USPSTF Recommendations For Colon Cancer Screening At Age 45 Could Give Cologuard A Boost

For more information on Medtech Insight and to start a free trial, click here:

http://bit.ly/2w7LnlR

Medtech Insight articles addressing topics discussed in this episode:

Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.

In this week’s podcast, Medtech Insight's senior reporters Sue Darcey and Ferdous Al-Faruque discuss which political candidates are getting campaign donations from the medtech industry in the 2020 US Senate and House elections, and where the US Food and Drug administration and other stakeholders including the medtech industry stand as the medical device user negotiations get under way.

Join us for an audio catch-up on the latest key developments in the worldwide biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.

In this week’s podcast, Medtech Insight's managing editor Marion Webb has an update from the virtual HLTH panel discussions on telehealth and robotics. Deputy editor Reed Miller discusses trial results from Boston Scientific’s next-generation Accurate neo2 self-expanding aortic valve presented during the Transcatheter Cardiovascular Therapeutics (TCT) meeting.

For more information on Medtech Insight and to start a free trial, click here:

http://bit.ly/2w7LnlR

Medtech Insight articles addressing topics discussed in this episode:

HLTH 2020: Panel Finds Pandemic Accelerates Uses For Robots In Health Care, Even ‘Zumba’

HLTH 2020: Amwell CEO Foresees Patient Demand Will Drive Telehealth’s Future

Boston Scientific’s TAVR Pipeline Delayed; FDA Approval Of Accurate neo2 Set For 2024